109 related articles for article (PubMed ID: 36067429)
21. Decomposition Analysis of Spending and Price Trends for Biologic Antirheumatic Drugs in Medicare and Medicaid.
McCormick N; Wallace ZS; Sacks CA; Hsu J; Choi HK
Arthritis Rheumatol; 2020 Feb; 72(2):234-241. PubMed ID: 31609057
[TBL] [Abstract][Full Text] [Related]
22. Roles of prices, poverty, and health in Medicare and private spending in Texas.
White C; Taychakhoonavudh S; Parikh R; Franzini L
Am J Manag Care; 2015 May; 21(5):e303-11. PubMed ID: 26167778
[TBL] [Abstract][Full Text] [Related]
23. Choosing wisely: prevalence and correlates of low-value health care services in the United States.
Colla CH; Morden NE; Sequist TD; Schpero WL; Rosenthal MB
J Gen Intern Med; 2015 Feb; 30(2):221-8. PubMed ID: 25373832
[TBL] [Abstract][Full Text] [Related]
24. Do Medicare Advantage Rebates Reduce Enrollees' Out-of-Pocket Spending?
Nicholas LH; Wu S
Med Care Res Rev; 2020 Oct; 77(5):474-482. PubMed ID: 30382801
[TBL] [Abstract][Full Text] [Related]
25. Comparing ambulatory commercial spending in Rhode Island and Massachusetts, 2016-2019.
James HO; Koller C; Nasuti LJ; Auerbach DI; Wilson IB
Health Serv Res; 2023 Dec; 58(6):1172-1177. PubMed ID: 37177796
[TBL] [Abstract][Full Text] [Related]
26. Insurer market structure and variation in commercial health care spending.
McKellar MR; Naimer S; Landrum MB; Gibson TB; Chandra A; Chernew M
Health Serv Res; 2014 Jun; 49(3):878-92. PubMed ID: 24303879
[TBL] [Abstract][Full Text] [Related]
27. US Spending Associated With Transition From Daily to 3-Times-Weekly Glatiramer Acetate.
Rome BN; Tessema FA; Kesselheim AS
JAMA Intern Med; 2020 Sep; 180(9):1165-1172. PubMed ID: 32897384
[TBL] [Abstract][Full Text] [Related]
28. The Relative Importance of Post-Acute Care and Readmissions for Post-Discharge Spending.
Huckfeldt PJ; Mehrotra A; Hussey PS
Health Serv Res; 2016 Oct; 51(5):1919-38. PubMed ID: 26841171
[TBL] [Abstract][Full Text] [Related]
29. Physician Participation in Medicare Accountable Care Organizations and Spillovers in Commercial Spending.
Post B; Ryan AM; Moloci NM; Li J; Dupree JM; Hollingsworth JM
Med Care; 2019 Apr; 57(4):305-311. PubMed ID: 30789539
[TBL] [Abstract][Full Text] [Related]
30. Projected Coding Intensity In Medicare Advantage Could Increase Medicare Spending By $200 Billion Over Ten Years.
Kronick R
Health Aff (Millwood); 2017 Feb; 36(2):320-327. PubMed ID: 28167722
[TBL] [Abstract][Full Text] [Related]
31. National Health Expenditure Projections, 2018-27: Economic And Demographic Trends Drive Spending And Enrollment Growth.
Sisko AM; Keehan SP; Poisal JA; Cuckler GA; Smith SD; Madison AJ; Rennie KE; Hardesty JC
Health Aff (Millwood); 2019 Mar; 38(3):491-501. PubMed ID: 30785832
[TBL] [Abstract][Full Text] [Related]
32. Assessment of Out-of-Pocket Spending for COVID-19 Hospitalizations in the US in 2020.
Chua KP; Conti RM; Becker NV
JAMA Netw Open; 2021 Oct; 4(10):e2129894. PubMed ID: 34661662
[TBL] [Abstract][Full Text] [Related]
33. A decade of increases in Medicare Part B pharmaceutical spending: what are the drivers?
San-Juan-Rodriguez A; Gellad WF; Shrank WH; Good CB; Hernandez I
J Manag Care Spec Pharm; 2021 May; 27(5):565-573. PubMed ID: 33908276
[No Abstract] [Full Text] [Related]
34. Temporal Patterns of High-Spend Subgroups Can Inform Service Strategy for Medicare Advantage Enrollees.
Amodeo SJ; Kowalkowski HF; Brantley HL; Jones NW; Bangerter LR; Cook DJ
J Gen Intern Med; 2022 Jun; 37(8):1853-1861. PubMed ID: 34100239
[TBL] [Abstract][Full Text] [Related]
35. Wide State-Level Variation In Commercial Health Care Prices Suggests Uneven Impact Of Price Regulation.
Chernew ME; Hicks AL; Shah SA
Health Aff (Millwood); 2020 May; 39(5):791-799. PubMed ID: 32364869
[TBL] [Abstract][Full Text] [Related]
36. Payer Type and Low-Value Care: Comparing Choosing Wisely Services across Commercial and Medicare Populations.
Colla CH; Morden NE; Sequist TD; Mainor AJ; Li Z; Rosenthal MB
Health Serv Res; 2018 Apr; 53(2):730-746. PubMed ID: 28217968
[TBL] [Abstract][Full Text] [Related]
37. The implications of regional variations in Medicare spending. Part 1: the content, quality, and accessibility of care.
Fisher ES; Wennberg DE; Stukel TA; Gottlieb DJ; Lucas FL; Pinder EL
Ann Intern Med; 2003 Feb; 138(4):273-87. PubMed ID: 12585825
[TBL] [Abstract][Full Text] [Related]
38. Health Care Spending, Utilization, and Quality 8 Years into Global Payment.
Song Z; Ji Y; Safran DG; Chernew ME
N Engl J Med; 2019 Jul; 381(3):252-263. PubMed ID: 31314969
[TBL] [Abstract][Full Text] [Related]
39. Variation In Health Spending Growth For The Privately Insured From 2007 To 2014.
Cooper Z; Craig S; Gray C; Gaynor M; Van Reenen J
Health Aff (Millwood); 2019 Feb; 38(2):230-236. PubMed ID: 30715989
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of Spending Differences Between Beneficiaries in Medicare Advantage and the Medicare Shared Savings Program.
Parikh RB; Emanuel EJ; Brensinger CM; Boyle CW; Price-Haywood EG; Burton JH; Heltz SB; Navathe AS
JAMA Netw Open; 2022 Aug; 5(8):e2228529. PubMed ID: 35997977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
